Fresh Tracks Therapeutics

Fresh Tracks Therapeutics, founded in 2009, is committed to pioneering innovation in medicine with a focus on autoimmune, inflammatory, and debilitating diseases. The company's leadership and board of directors boast a wealth of experience in early-stage research, product development, and global commercialization within the pharmaceutical and biotech industries, with successful track records in launching groundbreaking products such as Cialis®, Taltz®, and Prozac®. Fresh Tracks Therapeutics prides itself on its vision to expand beyond the limitations of current therapies and deliver exceptional solutions to those in need. The company operates within the Health Care, Health and Wellness, and Pharmaceutical industries, positioning itself at the forefront of medical innovation. Despite limited information on recent investments and headquarter location, Fresh Tracks Therapeutics stands as a promising player in the field, ready to make significant strides in the medical sector.